TTI-101 oral

News alerts, weekly reports and conference planners

Company:

Tvardi Therap

Drug class:

STAT3 inhibitor

Related drugs:

No biomarker	Hepatocellular Cancer	No biomarker	Hepatocellular Cancer	TTI-101 oral Sensitive: B - Late Trials TTI-101 oral Sensitive : B	TTI-101 oral Sensitive: B - Late Trials TTI-101 oral Sensitive : B
KRAS G12C	Lung Adenocarcinoma	KRAS G12C	Lung Adenocarcinoma	TTI-101 oral Sensitive: D – Preclinical TTI-101 oral Sensitive : D	TTI-101 oral Sensitive: D – Preclinical TTI-101 oral Sensitive : D

Associations
(2)